BR112023024776A2 - Métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos - Google Patents

Métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos

Info

Publication number
BR112023024776A2
BR112023024776A2 BR112023024776A BR112023024776A BR112023024776A2 BR 112023024776 A2 BR112023024776 A2 BR 112023024776A2 BR 112023024776 A BR112023024776 A BR 112023024776A BR 112023024776 A BR112023024776 A BR 112023024776A BR 112023024776 A2 BR112023024776 A2 BR 112023024776A2
Authority
BR
Brazil
Prior art keywords
platelets
compounds
systems
mononuclear
methods
Prior art date
Application number
BR112023024776A
Other languages
English (en)
Inventor
J Carroll Richard
Original Assignee
Prp Concepts Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prp Concepts Inc filed Critical Prp Concepts Inc
Publication of BR112023024776A2 publication Critical patent/BR112023024776A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/029—Separating blood components present in distinct layers in a container, not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0405—Lymph
    • A61M2202/0407—Lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0427—Platelets; Thrombocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes
    • A61M2202/0443—Macrophages, e.g. monocytes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0409—Moving fluids with specific forces or mechanical means specific forces centrifugal forces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Pathology (AREA)
  • Clinical Laboratory Science (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos. é fornecida uma composição de cicatrização de feridas de ocorrência não natural purificada, compreendendo plaquetas, monócitos, e linfócitos, em que a referida composição é substancialmente livre de neutrófilos. também é fornecido um sistema para preparar a referida composição de cicatrização de feridas de ocorrência não natural purificada; um método para preparar a composição; e um método de utilização da composição para tratar feridas.
BR112023024776A 2021-05-27 2022-05-12 Métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos BR112023024776A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163193889P 2021-05-27 2021-05-27
PCT/US2022/028941 WO2022250969A1 (en) 2021-05-27 2022-05-12 Methods and systems for preparation of mononuclear-platelet rich fibrin matrix, and compounds thereof

Publications (1)

Publication Number Publication Date
BR112023024776A2 true BR112023024776A2 (pt) 2024-02-15

Family

ID=84230155

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023024776A BR112023024776A2 (pt) 2021-05-27 2022-05-12 Métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos

Country Status (9)

Country Link
EP (1) EP4346850A1 (pt)
KR (1) KR20240022513A (pt)
CN (1) CN117545494A (pt)
AU (1) AU2022283171A1 (pt)
BR (1) BR112023024776A2 (pt)
CA (1) CA3219842A1 (pt)
CO (1) CO2023018206A2 (pt)
IL (1) IL308693A (pt)
WO (1) WO2022250969A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186840A (en) * 1976-03-04 1980-02-05 Becton, Dickinson And Company Cannulapierceable, self-sealing closure
US5494590A (en) * 1992-06-11 1996-02-27 Becton Dickinson Method of using anticoagulant solution in blood separation
GB201421013D0 (en) * 2014-11-26 2015-01-07 Turzi Antoine New standardizations & medical devices for the preparation of platelet rich plasma (PRP) or bone marrow centrate (BMC)
WO2017057076A1 (ja) * 2015-09-28 2017-04-06 富士フイルム株式会社 有核赤血球の取得方法および有核赤血球の識別方法

Also Published As

Publication number Publication date
WO2022250969A1 (en) 2022-12-01
KR20240022513A (ko) 2024-02-20
CN117545494A (zh) 2024-02-09
CA3219842A1 (en) 2022-12-01
CO2023018206A2 (es) 2024-03-07
AU2022283171A1 (en) 2024-01-04
EP4346850A1 (en) 2024-04-10
IL308693A (en) 2024-01-01

Similar Documents

Publication Publication Date Title
Badade et al. Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin
BR112019003543A2 (pt) suspensão celular para uso no tratamento da doença arterial periférica da extremidade inferior
BR112017018136A2 (pt) sistemas para tratamento de gás de escape e de gás de escape, e, método para tratamento de uma corrente de gás de escape.
BR112018015574A2 (pt) ?composto, medicamento, método para ativar um receptor tipo 2 da orexina e para profilaxia ou tratamento da narcolepsia, e, uso de um composto?
ECSP18081922A (es) Apósitos para heridas modificados
BRPI0506537A (pt) compostos que se ligam a membranas perturbadas e métodos de uso dos mesmos
BR112016025331A2 (pt) composições antimicrobianas
BR112014019144A8 (pt) Sistema de soldagem virtual, ferramenta de soldagem de imitação e método de uso de uma ferramenta de soldagem de imitação
AR045182A2 (es) Estructura absorbente, articulos absorbentes descartables y metodos para preparar la estructura absorbente.
BR112016009954A2 (pt) terapia para o tratamento ou prevenção de condições associadas a sangramento hipocoagulação
AR081450A1 (es) Tratamiento de sarcoidosis usando celulas madre de placenta
BR112015001151A2 (pt) métodos de manipulação de abacates e sistema
GB2462228A (en) Providing hemostasis in anticoagulated blood by using zeolites
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
BR112013000027A2 (pt) tratamento de distúrbios cognitivos
SG149875A1 (en) Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds
CO2020009747A2 (es) Métodos para purificar cannabinoides usando cromatografía líquido-líquido
BR112013010899A8 (pt) Curativo com uma camada de biocelulose com acabamento adsorvente de bactérias
Dalla Paola Diabetic foot wounds: the value of negative pressure wound therapy with instillation
CL2008002665A1 (es) Composicion farmaceutica compuesta por la fraccion flavonoide purificada micronizada de diosmina y hesperidina y el compuesto dobesilato de calcio; y uso para el control y tratamiento de la insuficiencia venosa cronica.
BR112022016425A2 (pt) Curativo hemostático, e, método para fabricar o mesmo
Sigle et al. Comparison of transfusion efficacy of amotosalen‐based pathogen‐reduced platelet components and gamma‐irradiated platelet components
BR112023024776A2 (pt) Métodos e sistemas para preparação de matriz de fibrina rica em plaquetas mononucleares e seus compostos
BRPI1103720E2 (pt) caixa para tomada
BR112013022217A8 (pt) composição farmacêutica, método de tratamento preventivo de uma síndrome hemorrágica em um paciente com hemofilia a ou b e método de tratamento de um acidente hemorrágico em um paciente com hemofilia a ou b